Change of Adviser

Summary by AI ^BETAClose X

Inspiration Healthcare Group plc has appointed Singer Capital Markets as its Nominated Adviser and Joint Broker with immediate effect, working alongside existing Joint Broker Cavendish Capital Markets. This strategic appointment is effective from April 14, 2026, and signifies a change in the company's advisory and brokerage services.

Disclaimer*

Inspiration Healthcare Group PLC

14 April 2026

Inspiration Healthcare Group plc

("Inspiration Healthcare", the "Company" or the "Group")

Appointment of Nominated Adviser and Joint Broker

Inspiration Healthcare Group plc (AIM: IHC), the global medical technology company, is pleased to announce the appointment of Singer Capital Markets as Nominated Adviser & Joint Broker to the Company with immediate eﬀect. Singer Capital Markets will work alongside Cavendish Capital Markets, the Group's existing Joint Broker.

For further information, please contact:

Inspiration Healthcare Group plc		Tel: +44 (0)330 175 0000
Raffi Stepanian, Chief Executive Officer
Alan Olby, Chief Financial Officer

Singer Capital Markets (Nominated Adviser & Broker)				Tel: +44 (0)20 3100 2000
Alex Bond
Phil Davies
Jalini Kalaravy

Cavendish Capital Markets (Joint Broker)			Tel: + 44 (0)20 7220 0500
Giles Balleny / Joe Smith
Nigel Birks
Harriet Ward

Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or inspirationhealthcare@walbrookpr.com
Anna Dunphy		Mob: +44 (0) 7876 741 001
Rachel Broad		Mob: +44 (0) 7747 515 393

About Inspiration Healthcare

Inspiration Healthcare (AIM: IHC) designs, manufactures and markets pioneering medical technology. Based in the UK, the Company specialises in neonatal intensive care medical devices, which are addressing a critical need to help to save the lives and improve the outcomes of patients, starting with the very first breaths of life.

The Company has a broad porfolio of its own products and complementary distributed products, for use in neonatal intensive care designed to support even the most premature babies throughout their hospital stay. Its own branded products range from highly sophisticated capital equipment such as ventilators for life support through to single-use disposables.

The Company sells its products directly to hospitals and healthcare providers in the UK and Ireland, where it also distributes a range of advanced medical technologies for infusion therapy. In the rest of the world the Company has an established network of distribution partners around the world giving access to more than 75 countries.

The Company operates in the UK from its world-class Manufacturing and Technology Centre in Croydon, South London and in the USA from its facility in Melbourne, Florida.

Further information on Inspiration Healthcare can be found at www.inspirationhealthcaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END